Ahmed Mohamed Abougabal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Mohamed Abougabal has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Hafez Afifi
Diagnostic Radiology Department, Faculty of Medicine, Alex University, Egypt
1 shared publicationAhmed Mohamed Rashad
Diagnostic and Interventional Radiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication- Ahmed Samir
Department of Radio-diagnosis, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
1 shared publication - Aya Abdel Galeel
Alexandria University, Department of Radiology, Alexandria, Egypt
1 shared publication - Ayman Ibrahim Baess
Department of Chest Diseases, Alexandria University, Alexandria, Egypt
1 shared publication Khaled Mohamed Moghazy
Diagnostic and Interventional Radiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication
Latest Publications
- Open Access
- 22 November 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-19
A stepwise multi-disciplinary algorithm for diagnosis of fibrosing lung diseases contributing MDCT, MRI, and PET/CT: a study on 250 patients using significance and validation analyses
Background: The new guidelines limited the use of lung biopsy in the evaluation of lung fibrosis because of its hazards. The differential diagnosis of interstitial pulmonary fibrosis (IPF) or usual interstitial pneumonia (UIP) is challenging because of overlapping multi-detector computed tomography (MDCT) morphologic features between interstitial and non-interstitial fibrosing lung diseases. Scar carcinoma is a serious complication that needs to be excluded in certain conditions. Aim of the work: To achieve a multi-disciplinary algorithm for the diagnosis of fibrosing lung diseases to limit the need for lung biopsy by combining the clinico-laboratory and radiological roles. Results: This study included two major steps. The first step (prevalence/significance analysis of the contributing parameters for the diagnosis of fibrosing lung diseases) was retrospectively conducted on 150 patients pathologically proved with fibrosing lung disease during the period between January/2016 and April/2018. Based on a P-value < 0.001, honeycombing bronchiectasis was significant to IPF. Basal traction bronchiectasis/bronchiolectasis was relevant to fibrosing non-specific interstitial pneumonia (NSIP). "Head cheese" CT-sign, history of allergen exposure, blood eosinophilia, and broncho-alveolar lavage (BAL) lymphocytosis were relevant to chronic hypersensitivity pneumonitis (HP). Upper peripheral lung fibrosis was significant to pulmonary tuberculosis (TB) and pleuroparenchymal fibroelastosis (PPFE). Cavitations, tree-in-bud, and calcific nodules were relevant to TB, while the "platy-thorax" CT-sign was relevant to PPFE. The upper peribronchovascular fibrosis was relevant to sarcoidosis and progressive massive fibrosis (PMF); additionally, calcific changes were relevant to PMF. Bright T2-signal, diffusion weighted-image (DWI) restriction in magnetic-resonance imaging (MRI), and high standardized uptake value (SUV) in positron emission tomography (PET-CT) were significant to scar carcinoma. Eventually, an algorithm was created. The second step (validation analysis) prospectively targeted 100 patients initially diagnosed with lung fibrosis during the period from June/2018 to June/2022. It revealed 83.3–100% sensitivity, 96.3–100% specificity, 85.7–100% PPV, 96.4–100% NPV, and 96–100% accuracy, with balanced accuracy = 0.91–1. Four consulting radiologists and two consulting pulmonologists participated in this study. Conclusions: A valid stepwise multi-disciplinary algorithm was proposed for the diagnosis of interstitial and non-interstitial fibrosing lung diseases to limit the need and hazards of lung biopsy. It contributed significant clinico-laboratory data, MDCT features, T2-WI and DWI-MRI findings as well as PET/CT results.
- 22 November 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-19
Open AccessA stepwise multi-disciplinary algorithm for diagnosis of fibrosing lung diseases contributing MDCT, MRI, and PET/CT: a study on 250 patients using significance and validation analyses
Background: The new guidelines limited the use of lung biopsy in the evaluation of lung fibrosis because of its hazards. The differential diagnosis of interstitial pulmonary fibrosis (IPF) or usual interstitial pneumonia (UIP) is challenging because of overlapping multi-detector computed tomography (MDCT) morphologic features between interstitial and non-interstitial fibrosing lung diseases. Scar carcinoma is a serious complication that needs to be excluded in certain conditions. Aim of the work: To achieve a multi-disciplinary algorithm for the diagnosis of fibrosing lung diseases to limit the need for lung biopsy by combining the clinico-laboratory and radiological roles. Results: This study included two major steps. The first step (prevalence/significance analysis of the contributing parameters for the diagnosis of fibrosing lung diseases) was retrospectively conducted on 150 patients pathologically proved with fibrosing lung disease during the period between January/2016 and April/2018. Based on a P-value < 0.001, honeycombing bronchiectasis was significant to IPF. Basal traction bronchiectasis/bronchiolectasis was relevant to fibrosing non-specific interstitial pneumonia (NSIP). "Head cheese" CT-sign, history of allergen exposure, blood eosinophilia, and broncho-alveolar lavage (BAL) lymphocytosis were relevant to chronic hypersensitivity pneumonitis (HP). Upper peripheral lung fibrosis was significant to pulmonary tuberculosis (TB) and pleuroparenchymal fibroelastosis (PPFE). Cavitations, tree-in-bud, and calcific nodules were relevant to TB, while the "platy-thorax" CT-sign was relevant to PPFE. The upper peribronchovascular fibrosis was relevant to sarcoidosis and progressive massive fibrosis (PMF); additionally, calcific changes were relevant to PMF. Bright T2-signal, diffusion weighted-image (DWI) restriction in magnetic-resonance imaging (MRI), and high standardized uptake value (SUV) in positron emission tomography (PET-CT) were significant to scar carcinoma. Eventually, an algorithm was created. The second step (validation analysis) prospectively targeted 100 patients initially diagnosed with lung fibrosis during the period from June/2018 to June/2022. It revealed 83.3–100% sensitivity, 96.3–100% specificity, 85.7–100% PPV, 96.4–100% NPV, and 96–100% accuracy, with balanced accuracy = 0.91–1. Four consulting radiologists and two consulting pulmonologists participated in this study. Conclusions: A valid stepwise multi-disciplinary algorithm was proposed for the diagnosis of interstitial and non-interstitial fibrosing lung diseases to limit the need and hazards of lung biopsy. It contributed significant clinico-laboratory data, MDCT features, T2-WI and DWI-MRI findings as well as PET/CT results.
- Open Access
- 7 September 2019
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 50 (1) , 1-10
Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in assessment of response to preoperative chemotherapy in pediatric sarcoma
- 7 September 2019
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 50 (1) , 1-10
Open AccessValue of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in assessment of response to preoperative chemotherapy in pediatric sarcoma
- Open Access
- 31 March 2013
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 44 (1) , 1-7
Role of multidetector computed tomography (MDCT) in diagnosis and staging of gall bladder carcinoma
- 31 March 2013
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 44 (1) , 1-7
Open AccessRole of multidetector computed tomography (MDCT) in diagnosis and staging of gall bladder carcinoma